9 Meters Biopharma Inc. (NASDAQ:NMTR) went down by -1.41% from its latest closing price compared to the recent 1-year high of $1.77. The company’s stock price has collected 62.98% of gains in the last five trading sessions. Press Release reported on 12/21/20 that 9 Meters Biopharma Announces Agreement with the European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications
Is It Worth Investing in 9 Meters Biopharma Inc. (NASDAQ :NMTR) Right Now?
Plus, the 36-month beta value for NMTR is at -3.75. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for 9 Meters Biopharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $4.33. NMTR currently public float of 116.68M and currently shorts hold a 2.60% ratio of that float. Today, the average trading volume of NMTR was 6.71M shares.
NMTR’s Market Performance
NMTR stocks went up by 62.98% for the week, with a monthly jump of 66.67% and a quarterly performance of 72.41%, while its annual performance rate touched 119.37%. The volatility ratio for the week stands at 22.35% while the volatility levels for the past 30 days are set at 12.56% for 9 Meters Biopharma Inc.. The simple moving average for the period of the last 20 days is 51.50% for NMTR stocks with a simple moving average of 107.81% for the last 200 days.
NMTR Trading at 59.24% from the 50-Day Moving Average
After a stumble in the market that brought NMTR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.90% of loss for the given period.
Volatility was left at 12.56%, however, over the last 30 days, the volatility rate increased by 22.35%, as shares surge +64.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +99.54% upper at present.
During the last 5 trading sessions, NMTR rose by +62.98%, in comparison to the 20-day moving average, which settled at $0.9516. In addition, 9 Meters Biopharma Inc. saw 62.98% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at NMTR starting from Sirgo Mark A, who purchase 230,769 shares at the price of $0.65 back on Dec 15. After this action, Sirgo Mark A now owns 774,066 shares of 9 Meters Biopharma Inc., valued at $150,000 using the latest closing price.
Temperato John, the Chief Executive Officer of 9 Meters Biopharma Inc., purchase 153,846 shares at $0.65 during a trade that took place back on Dec 15, which means that Temperato John is holding 977,522 shares at $100,000 based on the most recent closing price.